Furthermore, increased ACE2 concentrations may increase vulnerability to SARS-CoV-2 infection, particularly in patients with cardiac disease, hypertension, or diabetes who are taking ACE2-increasing drugs [18,19,20,21]. This evidence concerns the gene ACE2 and Hypertension.